Sutureless aortic valve replacement in high risk patients neutralizes expected worse hospital outcome: A clinical and economic analysis
- PMID: 30234906
- PMCID: PMC8086689
- DOI: 10.5603/CJ.a2018.0098
Sutureless aortic valve replacement in high risk patients neutralizes expected worse hospital outcome: A clinical and economic analysis
Abstract
Background: Aortic valve replacement (AVR) by sutureless prostheses is changing surgeon options, although which patients benefit most, as well as their possible economic impact is still to be defined.
Methods: Perceval-S prosthesis (LivaNova) is reserved, at the documented Institution, for patients at perceived high surgical risk. This retrospective analysis of outcome and resource consumption compared Perceval with other tissue valves. To clarify the comparison, only patients respecting 'instructions-for- use' of Perceval were reviewed.
Inclusion criteria: > 65 years, +/- coronary artery bypass grafting, patent foramen ovale closure or myectomy.
Exclusion criteria: bicuspid, combined valve or aortic sur- gery. Costs were calculated per patient on a daily basis including preoperative tests, operating costs (hourly basis), disposables, drugs, blood components and personnel.
Results: The sutureless group (SU-AVR) had a higher risk profile than the sutured group (ST-AVR). Cardiopulmonary bypass (CPB) and cross-clamp times were significantly shorter in SU-AVR (isolated AVR: cross-clamp 52.9 ± 12.6 vs. 69 ± 15.3 min, p < 0.001; CPB 79.4 ± 20.3 vs. 92.7 ± 18.2 min, p < 0.001). Hospital mortality was 0.9% in SU-AVR and nil in ST-AVR, p = 0.489; intubation 7 (IQR 5-10.7) and 7 h (IQR 5-9), p = 0.785; intensive care unit 1 (IQR 1-1) and 1 day (IQR 1-1), p = 0.258; ward stay 5.5 (IQR 4-7) and 5 days (IQR 4-6), p = 0.002; pacemaker 5.7% (6/106) and 0.9% (1/109), p = 0.063, respectively. Hospital costs (excluding the prosthesis) were $12,825 (IQR 11,733-15,334) for SU-AVR and $12,386 (IQR 11,217-14,230) in ST-AVR, p = 0.055.
Conclusions: Despite higher operative risks in SU-AVR, hospital mortality, morbidity and resource consumption did not differ. Operative times were shorter with the sutureless device and this improve- ment, along with more frequent ministernotomy, may have improved many postoperative aims.
Keywords: aortic valve; perceval; sutureless.
Conflict of interest statement
Similar articles
-
Sutureless Aortic Valve Replacement for Treatment of Severe Aortic Stenosis: A Single Technology Assessment of Perceval Sutureless Aortic Valve [Internet].Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Aug 25. Report from the Norwegian Institute of Public Health No. 2017-01. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Aug 25. Report from the Norwegian Institute of Public Health No. 2017-01. PMID: 29553663 Free Books & Documents. Review.
-
Immediate outcome after sutureless versus transcatheter aortic valve replacement.Heart Vessels. 2016 Mar;31(3):427-33. doi: 10.1007/s00380-014-0623-3. Epub 2015 Jan 9. Heart Vessels. 2016. PMID: 25573258
-
Sutureless and Transcatheter Aortic Valve Replacement: When Rivals Become Allies.Semin Thorac Cardiovasc Surg. 2020 Autumn;32(3):427-430. doi: 10.1053/j.semtcvs.2019.07.003. Epub 2019 Jul 19. Semin Thorac Cardiovasc Surg. 2020. PMID: 31330180
-
Sutureless Valve Replacement Through a Right Anterior Mini-thoracotomy in Elderly Patients With Stenotic Bicuspid Aortic Valve.Semin Thorac Cardiovasc Surg. 2019 Autumn;31(3):458-464. doi: 10.1053/j.semtcvs.2018.09.025. Epub 2018 Oct 13. Semin Thorac Cardiovasc Surg. 2019. PMID: 30321588
-
Sutureless Perceval Aortic Valve Versus Conventional Stented Bioprostheses: Meta-Analysis of Postoperative and Midterm Results in Isolated Aortic Valve Replacement.J Am Heart Assoc. 2018 Feb 16;7(4):e006091. doi: 10.1161/JAHA.117.006091. J Am Heart Assoc. 2018. PMID: 29453309 Free PMC article.
Cited by
-
Early and Long-Term Clinical and Echocardiographic Outcomes of Sutureless vs. Sutured Bioprosthesis for Aortic Valve Replacement.J Cardiovasc Dev Dis. 2023 May 22;10(5):224. doi: 10.3390/jcdd10050224. J Cardiovasc Dev Dis. 2023. PMID: 37233191 Free PMC article. Review.
-
A pooled analysis of pacemaker implantation after Perceval sutureless aortic valve replacement.Interact Cardiovasc Thorac Surg. 2021 Oct 4;33(4):501-509. doi: 10.1093/icvts/ivab137. Interact Cardiovasc Thorac Surg. 2021. PMID: 34000013 Free PMC article.
-
Sutureless aortic valve replacement in patients with active infective endocarditis: is it contraindicated or recommended?J Thorac Dis. 2022 Dec;14(12):4586-4589. doi: 10.21037/jtd-22-1365. J Thorac Dis. 2022. PMID: 36647460 Free PMC article. No abstract available.
-
An Analysis of Early Results after Valve Replacement in Isolated Aortic Valve Stenosis by Using Sutureless vs. Stented Bioprostheses: A Single-Center Middle-Income Country Experience.Medicina (Kaunas). 2023 May 26;59(6):1032. doi: 10.3390/medicina59061032. Medicina (Kaunas). 2023. PMID: 37374235 Free PMC article.
-
Clinical Midterm Results of Surgical Aortic Valve Replacement with Sutureless Valves.J Chest Surg. 2024 May 5;57(3):255-262. doi: 10.5090/jcs.23.142. Epub 2024 Mar 26. J Chest Surg. 2024. PMID: 38528758 Free PMC article.
References
-
- Max Roser 2016– ‘Life Expectancy’. Published online at OurWorldInData.org; https://ourworldindata.org/life-expectancy/(Online Resource)
-
- Canadian Agency for Drugs and Technologies in Health. Perceval S Sutureless Valve for Aortic Valve Replacement: A Review of the Clinical Effectiveness, Safety, and Cost-Effectiveness [Internet] Ottawa (ON): 2015. Jan 29, http://www.ncbi.nlm.nih.gov/books/NBK349716/ - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical